Walton and Nattrass1 introduced the term limbgirdle muscular dystrophy in 1954 as part of a classification of the muscular dystrophies which gained widespread acceptance and did much to resolve the confusion up to that ti-me. The cardinal features were:
(a) onset of shoulder or pelvic girdle weakness, usually in the second or third decade but sometimes in middle age; (b) absence of facial weakness; (c) a slowly progressive course with spread to all limbs and severe disability in most cases within 20 years;
(d) autosomal recessive inheritance. Over the following 30 years it has become clear that numerous inherited and acquired disorders can produce a similar clinical picture, including nemaline myopathy, central core disease, thyrotoxic and other endocrine myopathies, the various scapuloperoneal syndromes, chronic polymyositis, man-*Present address: Duncan Guthrie Institute of Medical Genetics, University of Glasgow, Yorkhill, Glasgow G3 8SJ.
Received for publication 3 April 1984. Accepted for publication 12 September 1984. ifesting female carriers of X linked Duchenne muscular dystrophy, sporadic cases of Becker muscular dystrophy, and, above all, spinal muscular atrophy. It is probable that a significant proportion of cases suspected of having limb-girdle muscular dystrophy in the past will have had one of these other disorders.2 It is not known to what extent this has reduced the apparent prevalence of limb-girdle muscular dystrophy. In children there is an autosomal recessive limb-girdle muscular dystrophy affecting the pelvic girdle and this may sometimes present in early adult life. Some authorities are now doubtful about the existence of a separate autosomal recessive lower limb-girdle muscular dystrophy of adult onset.2 In order to investigate this further we have studied cases of limb-girdle muscular dystrophy of adult onset in the Lothian Region of Scotland.
Methods
We attempted complete ascertainment of cases diagnosed as 'limb-girdle muscular dystrophy' with onset at 18 years of age or later and resident in the 
Discussion
The patients in this study show much diversity in their clinical features, particularly with regard to age at onset, pattern of muscle involvement, and course of the disease. The three cases with onset in the upper limbs have some features in common and will be discussed as a group. Patients with predominantly lower limb weakness and a pattern of muscle involvement similar to that seen in Becker muscular dystrophy form another distinct group that will be discussed below. JS, WB, and JL all had onset of weakness in the upper limbs. Initial symptoms related to weakness of the biceps in all cases and started in young adult life. Wasting of the upper arms was noticeable at an early stage. Weakness spread to the shoulders, particularly involving the lower fibres of trapezius, rhomboids, serratus anterior, pectoralis major, and latissimus dorsi. Scapular winging was a prominent feature. Deltoids and spinati were somewhat preserved. In the two older patients (WB and JL) progression had been very slow. Weakness had spread to the lower limbs after 10 to 20 years, initially affecting the proximal muscles, especially the hip flexors, and they were still ambulant at 55 and 69 years of age respectively. In both, contractures limiting abduction at the shoulder joint had developed later in the course of the disease. This pattern of wasting and weakness in the upper limbs is well described by the term scapulohumeral, and the clinical features in these three cases resemble the traditional juvenile type of muscular dystrophy first described by Erb.s Spinal muscular atrophy can produce an identical clinical picture and this diagnosis could not be excluded in JL or WB, who had not had muscle biopsies and declined further investigation. In JS the presence of some asymmetry of muscle involvement also pointed to this diagnosis, but muscle histology and electrophysiology were thought to favour muscular dystrophy, although neurogenic atrophy could not be completely excluded. Weakness and wasting of the sternomastoids in JS was also present in two cases reported by Walton and Nattrass.'
The majority of cases with onset in the pelvic girdle had calf hypertrophy and other features characteristic of Becker muscular dystrophy.2 6 Thus, in the shoulder girdle, weakness and wasting was most marked in the sternocostal fibres of pectoralis major and in latissimus dorsi. Involvement of biceps and triceps tended to lag behind the shoulder girdle muscles, and in two cases there was striking weakness of brachioradialis. Scapular winging was mild or absent. In the lower limbs weakness and wasting particularly affected hip flexion and extension and knee extension, hamstrings being relatively preserved. Values of serum creatine kinase were high.
PD and GN had this typical Becker phenotype. JB had several of these features. Furthermore, his maternal grandfather was confined to a wheelchair for much of his adult life. The family attributed this to 'dropsy', but the possibility of X linked muscular dystrophy cannot be excluded. In all three cases, the diagnosis of muscular dystrophy was confirmed by electromyography and muscle biopsy.
TW had extensive weakness of all the scapulohumeral muscles, but the costal fibres of pectoralis major, latissimus dorsi, and brachioradialis were noticeably more severely affected. Lower limb muscles were almost completely paralysed and at the time of our examination he had been confined to a wheelchair for 10 years. He did not have calf hypertrophy and had no recollection of having had prominent calves in the past. At presentation to a neurologist two years after onset of symptoms, his calves were said to show wasting. In contrast, it is clear from the hospital records that calf hypertrophy was present in his brother, FW, in whom a diagnosis of pseudohypertrophic muscular dystrophy had been made some time previously. They both had very high levels of serum creatine kinase. FW had biopsy findings confirming muscular dystrophy. Furthermore, at necropsy following a fatal accident, histology in several of his muscles showed the dystrophic process at varying stages of advancement and histological examination of the spinal cord and nerve roots was normal, ruling out spinal muscular atrophy. If Becker muscular dystrophy is accepted as the most probable diagnosis in FW, it is likely that his brother TW has the same condition, although the absence of calf hypertrophy would be an unusual feature.6 The pes cavus, mild quadriceps weakness, and patella instability in his daughter, CW, could be interpreted as minor manifestations of the condition in an obligate heterozygote, although if this is the correct explanation it is surprising that her serum creatine kinase was normal. A minority of carriers of the Duchenne muscular dystrophy gene exhibit some degree of weakness,7 but this appears to be rare for Becker muscular dystrophy carriers.8 EO was also thought to have calf hypertrophy, but less striking than in the cases mentioned above. In the absence of normal values for calf size this is inevitably a somewhat subjective assessment and extensive wasting of the quadriceps can give a false impression of calf enlargement. His pattern of muscle involvement was also compatible with a diagnosis of Becker muscular dystrophy and the serum creatine kinase was ten times the upper limit of the normal range. Electromyography and muscle biopsy were entirely consistent with a diagnosis of muscular dystrophy. Onset of symptonms at 45 years of age would be unusual for Becker muscular dystrophy but does not rule out this diagnosis.2
Of the ten index cases in this study, nine were male and this striking excess of males provides further support for the suggestion that some or all of the five patients discussed above were cases of Becker rather than limb-girdle muscular dystrophy. Further evidence for this might have come from the measurement of serum creatine kinase in their daughters, since 60% of obligate carriers of Becker muscular dystrophy have values above the normal range.9 However, none of their daughters was found to have a level above the normal 95th centile.
Of the two remaining patients with onset in the pelvic girdle, CC had a pattern of wasting and weakness in the upper limbs resembling that seen in scapulohumeral muscular dystrophy, but without marked winging of the scapulae. He had never had calf hypertrophy and his serum creatine kinase was normal. Electromyography suggested a myopathy but he declined muscle biopsy so that spinal muscular atrophy and other diagnoses could not be excluded. AM, the only female patient in this study, also had a scapulohumeral pattern of weakness in the upper limbs, but no winging of the scapulae. In the lower limbs she had predominantly proximal weakness, particularly affecting the quadriceps muscles. Electromyography and muscle biopsy both supported a diagnosis of muscular dystrophy. Her serum creatine kinase was high, being raised more than ten-fold. Onset at the age of 28 years would be unusually late for autosomal recessive muscular dystrophy of childhood, but not impossible since cases with onset as late as 27 years of age have been reported.'( However, in that and other studies, levels of serum creatine kinase greater than ten times the upper limit of the normal range have only been observed in childhood and adolescence. The very high enzyme level found in this patient raises the possibility that she might be a manifesting carrier of the Duchenne gene, as suggested by Moser and Emery.7 Previous studies of the frequency of limb-girdle muscular dystrophy have not distinguished adult from childhood onset, and have obtained values ranging from 0-9 to 3-3 per 100 000 for the prevalence, making no adjustment for incomplete ascertainment."1 12 The study by Walton" includes information about the age at onset of symptoms from which the prevalence of cases with adult onset can be estimated to be 0-6 per 100 000. With one possible exception, none of their patients had calf hypertrophy, so that it is unlikely that any cases of Becker muscular dystrophy were included, being allocated instead to their Duchenne muscular dystrophy group. Excluding cases with a Becker phenotype, the value of 0-7 per 100 000 for the prevalence in this region is little different from that found in north-east England almost 30 years ago. However, the prevalence in this region is lower if only proven cases of muscular dystrophy are included, being reduced to 0-3 per 100 000. Furthermore, the prevalence for all ages in the earlier report is the lowest value found in any study to date, suggesting that either this is an area with a particularly low frequency of this condition or, more likely, that ascertainment was incomplete. It is therefore probable that the prevalence we have observed does represent a decline, as would be expected with the recognition nowadays of numerous conditions causing the same pattern of weakness. Indeed, during the course of this study we came across patients with spinal muscular atrophy (four cases), as well as single cases of carnitine deficiency and thyrotoxic myopathy who might well have been misdiagnosed as limb-girdle muscular dystrophy in the past.
In the original publications on limb-girdle muscular dystrophy'i the evidence for autosomal recessive inheritance was unconvincing. The proband was the only affected subject in all but two of the 16 families in which the index case was not an only child. In one of these families a brother and sister were affected from a sibship of five, and in the remaining family two brothers were affected from a sibship of six and there was little doubt that their mother had also been affected. Using this and other data Morton and Chung'3 concluded that only 60% of cases could be the result of autosomal recessive inheritance and that the remaining 40% were phenocopies of unknown aetiology. In the present study the ten families contained only 11 affected subjects, significantly fewer than expected on the basis of autosomal recessive inheritance, even if complete ascertainment is assumed. Moreover, it is possible that in the family containing two affected brothers, the diagnosis was Becker muscular dystrophy. Excluding the five families where this diagnosis was thought likely, the number of affected subjects was still significantly less than predicted for an autosomal recessive mode of transmission. The evidence for autosomal recessive inheritance of limb-girdle muscular dystrophy might have been strengthened by the recognition of an increasing number of disorders causing proximal weakness which in the past would have introduced heterogeneity into the material used for segregation analysis. This has not been found and it probably remains true that a substantial proportion of cases are phenocopies of unknown aetiology. Adult onset limb-girdle muscular dystrophy appears to be a relatively rare condition and this diagnosis should only be entertained when other causes of such weakness have been excluded. Several of the patients in this study with a diagnosis of limb-girdle muscular dystrophy had features of Becker muscular dystrophy. It has been suggested that isolated cases with an unequivocal Becker phenotype should be counselled on the basis of X linked recessive inheritance.2 For equivocal cases, the situation is more difficult, but it would probably be unwise to counsel them on the basis of autosomal recessive inheritance and reassure their daughters that there was little risk to their offspring. There is an urgent need for a greater understanding of the biochemical basis of these disorders so that such diagnostic and genetic counselling dilemmas can be resolved. 
